EMFLAZA (Marathon Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the EMFLAZA drug offered from Marathon Pharmaceuticals, LLC. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Marathon Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | deflazacort |
| SUBSTANCE NAME: | DEFLAZACORT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-02-09 |
| END MARKETING DATE: | 0000-00-00 |
EMFLAZA HUMAN PRESCRIPTION DRUG Details:
| Item Description | EMFLAZA from Marathon Pharmaceuticals, LLC |
| LABELER NAME: | Marathon Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 22.75(mg/mL) |
| START MARKETING DATE: | 2017-02-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42998-505_36cf40a2-f9d3-4c1c-b1a8-3c7df73d4cf9 |
| PRODUCT NDC: | 42998-505 |
| APPLICATION NUMBER: | NDA208685 |
Other DEFLAZACORT Pharmaceutical Manufacturers / Labelers:
